139 related articles for article (PubMed ID: 29738458)
1. The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.
Rahman F; Chebbo M; Courtin N; Fotso Fotso A; Alessi MC; Riteau B
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738458
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B
Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551
[TBL] [Abstract][Full Text] [Related]
3. Formyl Peptide Receptor 2 Plays a Deleterious Role During Influenza A Virus Infections.
Tcherniuk S; Cenac N; Comte M; Frouard J; Errazuriz-Cerda E; Galabov A; Morange PE; Vergnolle N; Si-Tahar M; Alessi MC; Riteau B
J Infect Dis; 2016 Jul; 214(2):237-47. PubMed ID: 27034344
[TBL] [Abstract][Full Text] [Related]
4. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2.
Khau T; Langenbach SY; Schuliga M; Harris T; Johnstone CN; Anderson RL; Stewart AG
FASEB J; 2011 Feb; 25(2):483-96. PubMed ID: 20930115
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
6. Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-β-STAT3-dependent pathway.
Ampomah PB; Moraes LA; Lukman HM; Lim LHK
FASEB J; 2018 Mar; 32(3):1468-1478. PubMed ID: 29127186
[TBL] [Abstract][Full Text] [Related]
7. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model.
Schloer S; Hübel N; Masemann D; Pajonczyk D; Brunotte L; Ehrhardt C; Brandenburg LO; Ludwig S; Gerke V; Rescher U
FASEB J; 2019 Nov; 33(11):12188-12199. PubMed ID: 31398292
[TBL] [Abstract][Full Text] [Related]
8. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
10. Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action.
Li R; Liu T; Liu M; Chen F; Liu S; Yang J
J Agric Food Chem; 2017 May; 65(18):3665-3674. PubMed ID: 28417634
[TBL] [Abstract][Full Text] [Related]
11. The role of the Annexin-A1/FPR2 system in the regulation of mast cell degranulation provoked by compound 48/80 and in the inhibitory action of nedocromil.
Sinniah A; Yazid S; Perretti M; Solito E; Flower RJ
Int Immunopharmacol; 2016 Mar; 32():87-95. PubMed ID: 26803520
[TBL] [Abstract][Full Text] [Related]
12. Roles of neuraminidase in the initial stage of influenza virus infection.
Ohuchi M; Asaoka N; Sakai T; Ohuchi R
Microbes Infect; 2006 Apr; 8(5):1287-93. PubMed ID: 16682242
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of human influenza A virus replication by chloroquine.
Ooi EE; Chew JS; Loh JP; Chua RC
Virol J; 2006 May; 3():39. PubMed ID: 16729896
[TBL] [Abstract][Full Text] [Related]
14. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.
Guarner J; Falcón-Escobedo R
Arch Med Res; 2009 Nov; 40(8):655-61. PubMed ID: 20304252
[TBL] [Abstract][Full Text] [Related]
16. FPR2: A Novel Promising Target for the Treatment of Influenza.
Alessi MC; Cenac N; Si-Tahar M; Riteau B
Front Microbiol; 2017; 8():1719. PubMed ID: 28928730
[TBL] [Abstract][Full Text] [Related]
17. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lung fibroblast activation by annexin A1.
Jia Y; Morand EF; Song W; Cheng Q; Stewart A; Yang YH
J Cell Physiol; 2013 Feb; 228(2):476-84. PubMed ID: 22777765
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
20. Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis.
Arora S; Lim W; Bist P; Perumalsamy R; Lukman HM; Li F; Welker LB; Yan B; Sethi G; Tambyah PA; Fairhurst AM; Alonso S; Lim LH
Cell Death Differ; 2016 Jul; 23(7):1243-56. PubMed ID: 26943321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
